PT-141 (bremelanotide) is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. As a research chemical, it is available for laboratory research. It is not a controlled substance but requires a prescription for clinical human use.
Legal Disclaimer: This page is for informational purposes only and does not constitute legal advice. Regulatory status can change. Always consult a qualified legal professional and verify current regulations in your jurisdiction before purchasing or using any research chemical.
FDA-approved as Vyleesi (bremelanotide) for clinical use. Not a controlled substance. Available as a research chemical for laboratory research purposes.
Not approved by Health Canada for clinical use. Available for research purposes.
Not licensed by the MHRA for clinical use. Available for research purposes.
Not approved by the TGA for clinical use. Available for research purposes.
Not approved by the EMA as a medicinal product. Available for research purposes in most member states.
There is an important legal distinction between purchasing PT-141 as a research chemical and using it for human therapeutic purposes.
No. PT-141 (bremelanotide) is not listed as a controlled substance under the DEA Controlled Substances Act.
Yes. PT-141 is the research name for bremelanotide, which is marketed as Vyleesi by Palatin Technologies. The FDA-approved Vyleesi requires a prescription.
Research-grade PT-141 is available as a research chemical without a prescription for legitimate laboratory research purposes. Clinical use requires a prescription.
PT-141 is not specifically listed on the WADA prohibited list as of 2025. However, athletes should verify current guidelines before use.
PT-141 is not licensed as a medicine in the UK by the MHRA. It is available for research purposes but is not approved for clinical human use.
Purgo Labs provides HPLC-verified, third-party tested PT-141 for legitimate research purposes. Every batch includes a certificate of analysis.
Shop PT-141 at Purgo LabsMedical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.